Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses

BACKGROUND: Immunotherapy has demonstrated a limited clinical efficacy in approximately 5% of cholangiocarcinoma. The main challenges for an effective immunotherapy response in cholangiocarcinoma arise from the tumor microenvironment, which is poorly understood. METHODS: For a comprehensive analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Tao, Li, Keyu, Niu, Nan, Shao, Yingkuan, Ding, Ding, Thomas, Dwayne L., Jing, Hao, Fujiwara, Kenji, Hu, Haijie, Osipov, Arsen, Yuan, Chunhui, Wolfgang, Christopher L., Thompson, Elizabeth D., Anders, Robert A., He, Jin, Mou, Yiping, Murphy, Adrian G., Zheng, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962046/
https://www.ncbi.nlm.nih.gov/pubmed/35346322
http://dx.doi.org/10.1186/s13045-022-01253-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962046/
https://www.ncbi.nlm.nih.gov/pubmed/35346322
http://dx.doi.org/10.1186/s13045-022-01253-z

Ejemplares similares